COOPER COMPANIES, INC. (COO)

81 -0.96 (-1.17%)

As of 2025-12-31 19:16:12 EST

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.

Traded asNasdaq: COO
ISINUS2166485019
CIK0000711404
LEI—
EIN942657368
SectorMedical Devices
IndustryOphthalmic Goods
CEOAlbert G. White III
Employees15,000
Fiscal Year End1031
Address6101 BOLLINGER CANYON ROAD, SAN RAMON, CA, 94583
Phone9254603600
Websitehttp://coopercos.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
COOCOOPER COMPANIES, INC.2025-12-31 19:16:1281-0.96-1.17
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
COO0000711404COOPER COMPANIES, INC.US2166485019—942657368Nasdaq3851Ophthalmic Goods1031DE6101 BOLLINGER CANYON ROADSAN RAMONCA94583UNITED STATESUS92546036006101 BOLLINGER CANYON ROAD, SAN RAMON, CA, 945836101 BOLLINGER CANYON ROAD, SAN RAMON, CA, 94583COOPER COMPANIES INCMedical Devices1958Albert G. White III15,000http://coopercos.com16,200,000,000217,600,000195,978,026The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.2025-12-25 15:53:29
This is a preview of the latest data. Subscribe to access the full data.
COO Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
COO Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202516,200,000,000-1,400,000,000-7.9545195,978,026-3,604,600-1.8061
202417,600,000,000-1,200,000,000-6.383199,582,626150,056,644302.9857
202318,800,000,0001,100,000,0006.214749,525,982171,5980.3477
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Daniel G. McbrideChief Operating Officer, Executive Vice President2024759,616—3,099,769721,42563,6364,764,859
Holly R. SheffieldPresident2024624,679—2,249,799504,93416,1543,447,463
Albert G. WhitePresident20241,127,692—12,480,0561,702,00816,15415,427,631
Brian G. AndrewsChief Financial Officer, Treasurer, Executive Vice President2024650,000—2,400,194588,56916,1543,727,326
Gerard H. WarnerPresident2024548,718—2,000,048475,16216,1793,128,944
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2025500
2024400
2023400
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue4,092,400,0003,895,400,0003,593,200,000
Cost Of Revenue1,410,300,0001,299,700,0001,235,300,000
Gross Profit2,682,100,0002,595,700,0002,357,900,000
Research And Development Expenses172,200,000155,100,000137,400,000
General And Administrative Expenses1,627,800,0001,533,700,0001,501,200,000
Operating Expenses———
Operating Income682,900,000705,700,000533,100,000
Net Income374,900,000392,300,000294,200,000
Earnings Per Share Basic1.881.975.94
Earnings Per Share Diluted1.871.965.91
Weighted Average Shares Outstanding Basic199,100,000198,900,00049,500,000
Weighted Average Shares Outstanding Diluted200,000,000200,400,00049,800,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents110,600,000107,600,000120,800,000
Marketable Securities Current———
Accounts Receivable829,000,000717,000,000609,700,000
Inventories846,000,000802,700,000735,600,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current2,106,400,0001,951,500,0001,704,900,000
Marketable Securities Non Current———
Property Plant And Equipment2,079,900,0001,860,500,0001,628,800,000
Other Assets Non Current689,200,000660,600,000637,100,000
Total Assets Non Current10,288,400,00010,363,700,0009,954,000,000
Total Assets12,394,800,00012,315,200,00011,658,900,000
Accounts Payable300,400,000260,500,000261,900,000
Deferred Revenue127,900,000129,900,000123,600,000
Short Term Debt47,800,00033,300,00045,400,000
Other Liabilities Current426,100,000424,300,000363,300,000
Total Liabilities Current1,112,800,0001,022,800,000969,000,000
Long Term Debt2,457,500,0002,550,400,0002,523,800,000
Other Liabilities Non Current282,800,000311,600,000239,200,000
Total Liabilities Non Current3,042,900,0003,208,800,0003,138,900,000
Total Liabilities4,155,700,0004,231,600,0004,107,900,000
Common Stock21,800,00021,700,0005,400,000
Retained Earnings7,643,300,0007,268,400,0006,876,100,000
Accumulated Other Comprehensive Income-406,500,000-421,700,000-453,800,000
Total Shareholders Equity8,238,900,0008,083,400,0007,550,800,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization377,400,000201,200,000186,200,000
Share Based Compensation Expense70,500,00075,100,00062,100,000
Other Non Cash Income Expense———
Change In Accounts Receivable120,300,000117,100,00060,200,000
Change In Inventories46,000,00059,300,000105,400,000
Change In Non Trade Receivables———
Change In Other Assets74,500,000132,500,00089,400,000
Change In Accounts Payable8,000,0009,300,0005,500,000
Change In Other Liabilities27,900,0003,600,00071,800,000
Cash From Operating Activities796,100,000709,300,000607,500,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment362,400,000421,200,000392,500,000
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-372,900,000-764,600,000-449,000,000
Tax Withholding For Share Based Compensation24,800,00030,300,00013,100,000
Payments Of Dividends——3,000,000
Issuance Of Common Stock10,600,0008,300,0007,900,000
Repurchase Of Common Stock290,100,00000
Issuance Of Long Term Debt3,111,100,0003,524,200,0002,124,200,000
Repayment Of Long Term Debt3,205,200,0003,506,800,0001,953,900,000
Other Financing Activities5,400,00055,600,00015,100,000
Cash From Financing Activities-425,900,00039,200,000-173,900,000
Change In Cash2,900,000-13,200,000-17,700,000
Cash At End Of Period110,600,000107,600,000120,800,000
Income Taxes Paid100,000,00078,400,00067,800,000
Interest Paid115,100,000134,800,000117,500,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share1.881.975.94
Price To Earnings Ratio37.186253.137113.1208
Earnings Growth Rate-4.5685-66.835-24.1379
Price Earnings To Growth Ratio-8.1396-0.795-0.5436
Book Value Per Share41.381740.6415152.5455
Price To Book Ratio1.68942.57570.5109
Ebitda952,300,000786,200,000653,500,000
Enterprise Value16,313,781,00023,296,952,0006,306,306,250
Dividend Yield——0.0008
Dividend Payout Ratio——0.0102
Debt To Equity Ratio0.30410.31960.3403
Capital Expenditures596,800,000432,900,000401,300,000
Free Cash Flow199,300,000276,400,000206,200,000
Return On Equity0.04550.04850.039
One Year Beta0.76590.7041.048
Three Year Beta0.84360.95950.9613
Five Year Beta0.88660.91450.9202
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Lucchese Cynthia LDirector2025-12-221,784A9,445
Rivas MariaDirector2025-12-181,000A11,141
Kurzius Lawrence ErikDirector2025-12-172,000A7,777
White Albert G IIIDirector, President & CEO2025-12-1610,000A236,151
Sheffield Holly RPresident, CSI2025-12-161,230A39,052
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Rob Bresnahan2025-06-09PA08Sale2025-05-15—$1,001 - $15,000
Thomas Suozzi2022-12-19NY03Sale2017-01-05—$15,001 - $50,000
Alan S. Lowenthal2015-05-02CA47Sale2015-04-20Spouse$15,001 - $50,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Cape Investment Advisory, Inc.2025-09-3065,54395668.5596
NEW MEXICO EDUCATIONAL RETIREMENT BOARD2025-09-30617,0009,00068.5556
Alecta Tjanstepension Omsesidigt2025-09-30107,112,3901,563,00068.53
Allworth Financial LP2025-09-3081,4501,18868.5606
JPMORGAN CHASE & CO2025-09-3094,372,4111,376,49368.56
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
TCW ETF Trust2025-10-31TCW Transform 500 ETFVOTE3,134219,097.940.0233
iSHARES TRUST2025-10-31iShares Low Carbon Optimized MSCI ACWI ETFCRBN6,267438,125.970.0441
iSHARES TRUST2025-10-31iShares MSCI ACWI ETFACWI51,7073,614,836.370.0153
iSHARES TRUST2025-10-31iShares MSCI Kokusai ETFTOK60041,9460.0184
WASHINGTON MUTUAL INVESTORS FUND2025-10-31Class 529-F-3FWWMX1,358,64794,983,011.770.0458
This is a preview of the latest data. Subscribe to access the full data.